Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-26 @ 2:19 AM
Study NCT ID:
NCT07217860
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-12-19
First Post:
2025-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Sponsor:
Xenon Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2029-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-08
Completion Date Type:
ESTIMATED
First Submit Date:
2025-10-14
First Submit QC Date:
None
Study First Post Date:
2025-10-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-17
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED